Please assess the completion status of the following clinical trial:

Trial Title: Nitric Oxide Donor Isosorbide Mono Nitrate for Induction of Labor With Pre-labor Rupture of Membranes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Singleton pregnancy.~* Cephalic presentation.~* Bishop score \< or = 6.~* Average size of the fetus.~* Adequate pelvic dimensions.~* Prelabour rupture of membranes.~* Term or post-term pregnancies with an indication for labor induction either maternal or fetal.~Exclusion Criteria:~* Previous uterine scar (e.g. caesarian delivery or unknown uterine incision , previous hysterotomy or myomectomy of the uterine corpus involving entry of the uterine cavity or extensive myometrial dissection, previous uterine rupture)~* Patients with regular uterine contractions.~* Malpresentation.~* Multifetal gesta1tion.~* Established fetal distress ( e.g. thick meconium stained liguor or non reassuring CTG changes)~* Indication for CS, e.g. Major degree of cephalopelvic disproportion and fetal macrosomia.~* Placenta previa or vasa previa.~* Active genital herpes infection.~* Severe maternal illness (e.g. severe preeclampsia).~* Laboratory and clinical sign of chorioamnionitis.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- isosorbide mono-nitrate group (Type: EXPERIMENTAL): 70 pregnant females, induction of labor will be done by Intra vaginal isosorbide mono nitrate (Effox 40 mg MINAPHARM)
- placebo group (Type: PLACEBO_COMPARATOR): 70 pregnant females, induction will be done by placebo (pyridoxine) administered in the posterior vaginal fornix.

Based on this trial design, predict the completion outcome and termination type (if applicable).